Moderna, Inc. Price Today
Moderna, Inc.
MRNA
Healthcare
$41.24B
💰
Market Cap
9.3
💸
Price to Earnings
$11.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
13 |
Strong Buy |
4 |
Hold |
10 |
Sell |
2 |
Strong Sell |
0 |
MRNA Price Forecast Target
108.2 👉 390.0 +260%
MRNA EPS Forecast
11.6 👉 -4.4 +-138%
Financials
Profit Margin
11 %
Revenue Growth
-92.8 %
Dividend
$ 0
Held Percent
9.7% - Insiders
69.5% - Institutions
20.8% - Public
Major Fund Holders
-
💰 Baillie Gifford and Company $5.6B
-
💰 Vanguard Group Inc $4.2B
-
💰 Blackrock Inc. $3.9B
-
💰 State Street Corporation $2.2B
-
💰 Flagship Pioneering Inc. $2.0B
Stock Ideas
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…📮FAQ
Some Frequently Asked Questions.
The Moderna, Inc. industry is Biotechnology
The Moderna, Inc. sector is Healthcare
The Moderna, Inc. forecasted predicted Price to Earnings PE ratio is -24.5
The Moderna, Inc. Price to Earnings PE ratio is 9.3
The Market Capitalization of Moderna, Inc. is $41.24B
There are total of 343568541 float shares with 69.5% held by Institutions and 9.7% held by insiders
The MModerna, Inc. forecasted Earnings per Share EPS is $-4.4
The Moderna, Inc. Earnings per Share EPS is 11.6
The Moderna, Inc. company has $10552000000 gross profits with 11 profit margins
The Moderna, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Moderna, Inc. Revenue is $10654000128 with -0.928 revenue growth
The price target for Moderna, Inc. stock is $390.0 for the high target and $74.4 for the low target
The consensus analyst recommendations for Moderna, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Moderna, Inc. is Buy, with the following breakdown:
- Buy: 13
- Strong Buy: 4
- Hold: 10
- Sell: 2
- Strong Sell: 0
The Beta of Moderna, Inc. is 1.6
The dividend of Moderna, Inc. is $0
The dividend yield of Moderna, Inc. is 0%
The biggest institutional and mutual fund holders of Moderna, Inc. stock are
- Baillie Gifford and Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Moderna, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0